Omega-3s, the OmegaCheck Test, and What They Mean for Your Heart and Inflammation

“Take fish oil” is some of the most common — and most vaguely justified — advice in health. But there’s a real science here, and a simple blood test that turns it from guesswork into something you can actually measure and improve. Let’s make sense of it.

Omega-3 fatty acids are essential fats — meaning your body can’t make them, so they have to come from food. They’re built into the membranes of every cell, and they’re the raw material your body uses to make signaling molecules that govern inflammation, blood clotting, and blood vessel function. After menopause, when cardiovascular risk rises and low-grade inflammation tends to creep up, paying attention to these fats becomes more relevant, not less.

Quest’s OmegaCheck panel is a nice way in, because it turns an abstract idea into numbers you can track. So let’s start there.

What the OmegaCheck panel actually measures

OmegaCheck reports several values. Here’s what each one means, in plain terms:

A useful way to think about it

Omega-6 and omega-3 aren’t “bad fat” and “good fat.” Both are essential. The body uses them to make opposing signals — one set that ramps inflammation up (helpful for healing an injury) and one that resolves it. Modern Western diets tend to oversupply omega-6 and undersupply omega-3, leaving many of us tilted toward the “inflammation on” side. The goal isn’t to eliminate omega-6 — it’s to raise omega-3 enough to restore balance.

The cardiovascular story — honestly told

This is where I want to be precise, because the headlines have whipped back and forth and left a lot of women confused.

What’s solid: Across large population studies, people with higher blood levels of EPA and DHA consistently have lower rates of heart disease, heart attack, and cardiovascular death. And omega-3s reliably lower triglycerides — one of the lipid markers that often drifts upward in midlife.

Where it gets nuanced: The big randomized trials of omega-3 supplements have been genuinely mixed. The clearest positive result, REDUCE-IT, used a high-dose, purified, prescription-grade EPA (not an over-the-counter capsule) in people with elevated triglycerides already on a statin, and showed a meaningful reduction in cardiovascular events. But a very similar trial, STRENGTH, using a combined EPA+DHA formulation, showed no such benefit. Researchers are still untangling why — the formulation, the dose, and even the placebo oils differed.

The honest takeaway on the heart

Omega-3s are clearly helpful for lowering triglycerides, and higher blood levels track with better heart outcomes. But a standard drugstore fish-oil capsule has not been proven to prevent heart attacks in otherwise healthy people. The strongest cardiovascular benefit comes from prescription-strength EPA in higher-risk patients — a decision to make with your physician, not a reason for everyone to megadose fish oil.

Inflammation — what’s real and what’s hype

“Anti-inflammatory” is one of the most overused words in wellness marketing. But for omega-3s, there’s genuine biology behind it: EPA and DHA are converted into specialized molecules (called resolvins and protectins) that actively help switch off inflammation once it’s done its job. This is real, and it’s measurable.

Where that translates into proven clinical benefit is more specific than the marketing implies:

Rheumatoid arthritis — genuinely helpful for symptoms

This is the strongest “specific condition” story. In people who already have RA, higher-dose omega-3s (around 2.7 g/day of combined EPA+DHA) can reduce joint pain, morning stiffness, and tender joint counts, and may reduce reliance on anti-inflammatory drugs. Important nuance: omega-3s help manage RA symptoms — they don’t prevent you from developing RA, and they don’t replace disease-modifying medication.

Dry eye disease — solid evidence

Multiple trials show omega-3 supplementation improves dry-eye symptoms and tear film stability — relevant for many midlife and postmenopausal women, who experience dry eye at higher rates as estrogen declines.

Menstrual pain — modest but real

For women still cycling, omega-3s have shown reductions in the intensity of primary dysmenorrhea (period pain) in several studies.

Where evidence is weaker or mixed

For general “whole-body inflammation,” mood, cognition, and the prevention (rather than treatment) of autoimmune disease, the data are inconsistent. Omega-3s may nudge inflammatory markers like CRP, but “lower CRP” doesn’t automatically mean “feel better” or “live longer.” Be skeptical of any product promising omega-3s as an anti-inflammatory cure-all.

“So will fish oil help my menopausal joint aches?”

This is one of the most common — and most reasonable — questions I get, so let me answer it carefully, because the honest answer is more useful than a hopeful one.

Probably not for that specific cause — and here’s why. The strong omega-3 joint evidence comes almost entirely from rheumatoid arthritis, which is an autoimmune disease: the joint pain there is driven by the immune system attacking the joint lining. Omega-3s help precisely because they dial down that immune-inflammatory cascade.

The joint aches that show up in perimenopause and menopause — sometimes called estrogen-deficiency arthralgia — are a different animal. Estrogen itself helps maintain cartilage, tendon, and joint tissue and has its own calming effect on pain and inflammation. When estrogen declines, many women notice new stiffness and aching, especially in the hands, knees, and shoulders. But because the underlying mechanism isn’t the same as rheumatoid arthritis, the fish-oil evidence doesn’t automatically carry over — and there isn’t good trial data showing omega-3s relieve menopausal joint pain specifically.

What actually has evidence for menopausal joint pain

For the joint aches tied to the menopause transition, the better-supported approaches are:

• Menopause hormone therapy, when you’re an appropriate candidate — joint pain is a genuine, often under-recognized menopausal symptom, and estrogen has been associated with less frequent joint pain.
• Strength training and movement, which support the joints, tendons, and surrounding muscle.
• Weight management and treating any coexisting osteoarthritis directly.

None of this means omega-3s are off the table. They’re low-risk, and if you also have osteoarthritis, an autoimmune condition, or simply want to try them, you’re not doing any harm — I just can’t honestly promise they’ll fix the menopausal piece. One more important point: if joint pain is significant, symmetric, involves swelling, or comes with prolonged morning stiffness, that deserves a real evaluation. Rheumatoid arthritis can first appear around the menopausal years, and it’s a diagnosis you don’t want to miss by assuming every midlife joint ache is “just hormones.”

How to actually improve your numbers

Food first — the best-supported approach

• Fatty fish, 2–3 times per week: salmon, sardines, mackerel, herring, anchovies, trout. This is the single most reliable way to raise your levels, and it comes with benefits a capsule can’t replicate.
• Plant sources of ALA (walnuts, flax, chia) are healthy, but the body converts ALA to EPA/DHA poorly — so they help less with your OmegaCheck numbers than fish does.
• Ease off excess omega-6 by reducing ultra-processed and deep-fried foods — not by fearing nuts, seeds, or olive oil.

Supplements — reasonable when food isn’t enough

• Fish oil (EPA+DHA): a typical supportive dose is roughly 1–2 g of combined EPA+DHA daily; higher doses (2–4 g) are sometimes used for triglyceride lowering or RA, ideally under medical guidance.
• Algae-based omega-3 is an excellent vegetarian/vegan option that supplies EPA and DHA directly.
• Quality matters: choose third-party-tested products to limit oxidation and contaminants; storing them cold and taking them with a meal improves tolerance.
• Retest after 8–16 weeks — red blood cell fatty acids turn over slowly, so give changes time before judging them.

Important safety notes

Bleeding risk: Omega-3s have a mild blood-thinning effect. If you take an anticoagulant or antiplatelet medication, or have surgery scheduled, talk with your physician before using higher doses.

Atrial fibrillation: High-dose prescription omega-3s have been associated with a small increased risk of atrial fibrillation (an irregular heart rhythm) in trials. This is one more reason high doses should be a deliberate, supervised decision — not a casual self-prescription.

The bottom line

• The OmegaCheck test is a legitimately useful tool — it turns “should I take fish oil?” into a measurable, trackable number.
• For your heart: omega-3s reliably lower triglycerides and higher levels track with better outcomes, but standard fish-oil capsules aren’t proven to prevent heart attacks in healthy people. The strongest benefit is prescription EPA in higher-risk patients.
• For inflammation: the clearest wins are rheumatoid arthritis symptoms and dry eye — not a vague whole-body “anti-inflammatory” promise.
• For menopausal joint aches specifically: omega-3s aren’t the answer — that’s a job for hormone therapy (if you’re a candidate) and strength training, since the cause is estrogen-related, not autoimmune.
• To improve your numbers: eat fatty fish 2–3 times a week first; supplement (fish or algae oil) if food isn’t enough; retest after a few months.
• Mind the cautions: bleeding risk with blood thinners, and a small atrial-fibrillation signal at high doses.

Omega-3s are one of the better-supported additions to a midlife health plan — not a miracle, but a real, measurable, food-first lever worth understanding.

If you’ve had an OmegaCheck drawn and aren’t sure what your numbers mean for you specifically — given your lipids, your medications, and your personal cardiovascular risk — that’s exactly the kind of thing worth reviewing together rather than chasing a single target on a page.

Selected References

Quest Diagnostics. OmegaCheck Test Summary and Test Detail (components: EPA, DPA, DHA, LA, AA, AA/EPA and omega-6/omega-3 ratios; correlation with Omega-3 Index r=0.91).

1. Bhatt DL, et al. Cardiovascular risk reduction with icosapent ethyl for hypertriglyceridemia (REDUCE-IT). N Engl J Med. 2019;380(1):11–22.
2. Nicholls SJ, et al. Effect of high-dose omega-3 (EPA+DHA) on cardiovascular events in high-risk patients (STRENGTH). JAMA. 2020;324(22):2268–2280.
3. N-3 fatty acids (EPA and DHA) and cardiovascular health — updated review of mechanisms and clinical outcomes (2020–2025). PMC12628397.
4. Omega-3 supplementation and lipid/plaque outcomes in coronary disease: systematic review and dose–response meta-analysis. Food Sci Nutr. 2025.
5. Wang et al. Omega-3 supplementation in rheumatoid arthritis: meta-analysis of 18 RCTs (~2.7 g/day EPA+DHA reduces pain and stiffness). Clin Rheumatol. 2024.
6. Efficacy of omega-3 intake in managing dry eye disease: systematic review and meta-analysis of 19 RCTs (4246 patients). 2023.
7. Meta-analysis: omega-3 intake and risk of RA occurrence (no reduction in RA onset). Nutrients. 2023;15:539.
8. Omega-3 fatty acids and chronic pain / primary dysmenorrhea: systematic review and meta-analysis. Front Med. 2025.

This article is for educational purposes and reflects the state of the evidence at the time of writing; it is not a substitute for individualized medical advice. Supplement quality is not uniformly regulated. Please discuss omega-3 testing, dosing, and any supplement with your own clinician — particularly if you take blood-thinning medication, have a heart rhythm disorder, or have surgery planned.